BioWorld

Oct. 13, 2008

View Archived Issues

Stock Winners and Losers For The Week

Public Financing of Biotechnology: September 2008

Other Financings of Public Biotechnology Companies: September 2008

Venture Capital and Other Investments in Private Biotechnology Companies: September 2008

Milestone Payments from Corporate Partners: September 2008

Money Raised in 2008

More Biotech Bankruptcies Might Not Be All Bad

A recent analysis by Jefferies & Co. Inc. of more than 300 loss-making biotechs showed that about 43 percent of the companies are operating with less than a year of cash. (BioWorld Financial Watch) Read More

Money Raised Year to Date

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2026.

Janssen Pharmaceutica reports new TMEM175 activators

BioWorld Science

Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...

Cancer specter looming, Abtect effect in UC wallops Abivax

BioWorld

Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...

FB-7033 demonstrates efficacy in MASH management

BioWorld Science

17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...

Illustration of antibody carrying radioactive isotope

Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC

BioWorld Science

At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...